clinical trial · NCT01228747
A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)
UCB Japan Co. Ltd.·phase3·completed·n = 361
EpilepsyGeneralized Tonic-Clonic SeizuresLevetiracetamPlacebo
brief summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of levetiracetam treatment used as adjunctive therapy in Japanese and Chinese epilepsy patients aged ≥16 years and with uncontrolled Generalized Tonic-Clonic seizures despite treatment with 1 or 2 anti-epileptic drugs.
started
Oct 1, 2010
primary completion
Apr 1, 2014
completion
May 1, 2014
last updated
Apr 3, 2025
official title
A Double-blind, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adjunctive Treatment With Oral Levetiracetam, in Epilepsy Patients Aged ≥16 Years, With Generalized Tonic-clonic (GTC) Seizures
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol